![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Urquima S.a. Palau-solità I Plegamans Es, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Flutrimazole, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 1999-108 - Rev 04
This Chemical Type CEP, issued on November 20, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1424 associated with this CEP further emphasizes